You are here

  • Home
  • Archive
  • Volume 58, Issue 10
  • Globotriaosylsphingosine (lyso-Gb3) and analogues in plasma and urine of patients with Fabry disease and correlations with long-term treatment and genotypes in a nationwide female Danish cohort

Article info

Article menu
Download PDFPDF
Biochemical genetics
Original research
Globotriaosylsphingosine (lyso-Gb3) and analogues in plasma and urine of patients with Fabry disease and correlations with long-term treatment and genotypes in a nationwide female Danish cohort

Authors

  1. Correspondence to Dr Christiane Auray-Blais, Pediatrics, Université de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada; christiane.auray-blais{at}usherbrooke.ca
View Full Text

Citation

Effraimidis G, Feldt-Rasmussen U, Rasmussen ÅK, et al
Globotriaosylsphingosine (lyso-Gb3) and analogues in plasma and urine of patients with Fabry disease and correlations with long-term treatment and genotypes in a nationwide female Danish cohort
Journal of Medical Genetics 2021;58:692-700.

Publication history

  • Received May 4, 2020
  • Revised July 14, 2020
  • Accepted August 3, 2020
  • First published September 22, 2020.
Online issue publication 
September 22, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.